GOTTSCHALK ADRIAN (CIK 1828724) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-13). Recent activity: Sell FHTX (47,497 shares), Buy FHTX (47,497 shares), Sell FHTX (59,208 shares), Buy FHTX (59,208 shares), Sell FHTX (300,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-13 | Foghorn Therapeutics Inc. (FHTX) | Chief Executive Officer | Sell | 47,497 | $0 |
| 2026-04-13 | Foghorn Therapeutics Inc. (FHTX) | Chief Executive Officer | Buy | 47,497 | $0 |
| 2026-04-13 | Foghorn Therapeutics Inc. (FHTX) | Chief Executive Officer | Sell | 59,208 | $0 |
| 2026-04-13 | Foghorn Therapeutics Inc. (FHTX) | Chief Executive Officer | Buy | 59,208 | $0 |
| 2025-04-28 | Foghorn Therapeutics Inc. (FHTX) | Chief Executive Officer | Sell | 300,000 | $0 |
| 2025-04-28 | Foghorn Therapeutics Inc. (FHTX) | Chief Executive Officer | Buy | 300,000 | $0 |
| 2025-04-10 | Foghorn Therapeutics Inc. (FHTX) | Chief Executive Officer | Sell | 197,906 | $0 |
| 2025-04-10 | Foghorn Therapeutics Inc. (FHTX) | Chief Executive Officer | Buy | 197,906 | $0 |
Source: SEC Form 4 filings · as of 2026-04-13